Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |